Title:

Wyeth v. Diana Levine

Subject:

Product Liability, Prescription Drugs, Drug Labeling, Administrative Law, Federal Food, Drug, and Cosmetic Act

Question:

Whether the prescription drug labeling judgments imposed on manufacturers by the Food and Drug Administration ("FDA") pursuant to FDA's comprehensive safety and efficacy authority under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. section 301 et seq., preempt state law product liability claims premised on the theory that different labeling judgments were necessary to make drugs reasonably safe for use.

Decisions:

Resources:

• Docket Sheet From the U.S. Supreme Court.